Woodline Partners’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.55M Buy
316,762
+77
+0% +$2.49K 0.04% 522
2025
Q4
$11M Buy
316,685
+109,247
+53% +$3.86M 0.04% 435
2025
Q3
$7.54M Sell
207,438
-39,060
-16% -$1.33M 0.04% 495
2025
Q2
$7.74M Sell
246,498
-81,747
-25% -$2.54M 0.04% 477
2025
Q1
$9.74M Buy
328,245
+186
+0.1% +$5.58K 0.06% 365
2024
Q4
$9.68M Buy
328,059
+53,378
+19% +$1.69M 0.07% 350
2024
Q3
$8.55M Buy
274,681
+643
+0.2% +$23.4K 0.07% 325
2024
Q2
$9.29M Hold
274,038
0.09% 256
2024
Q1
$17.8M Buy
274,038
+173,710
+173% +$11.9M 0.16% 187
2023
Q4
$6.85M Buy
+100,328
New +$5.21M 0.07% 274

Other funds holding IMCR